146 related articles for article (PubMed ID: 12956121)
1. [Future of use of molecular techniques in diagnosis and treatment of ovarian cancer].
Ma D
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):193-4. PubMed ID: 12956121
[No Abstract] [Full Text] [Related]
2. Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma.
Torng PL; Lee YC; Huang CY; Ye JH; Lin YS; Chu YW; Huang SC; Cohen P; Wu CW; Lin CT
Oncogene; 2008 Apr; 27(15):2137-47. PubMed ID: 17952116
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of ovarian cancer related oncogenes and tumor suppressor genes].
Neng J; Lang J
Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):756-8. PubMed ID: 8728923
[No Abstract] [Full Text] [Related]
4. [Role of genome research in the diagnosis and therapy of ovarian cancer].
Malek AV; Bakhidze EV
Vopr Onkol; 2005; 51(2):182-6. PubMed ID: 16222997
[No Abstract] [Full Text] [Related]
5. Gene expression and prognostic significance in ovarian cancer.
Tammela J; Odunsi K
Minerva Ginecol; 2004 Dec; 56(6):495-502. PubMed ID: 15729202
[TBL] [Abstract][Full Text] [Related]
6. From gene therapy to virotherapy for ovarian cancer.
Stoff-Khalili MA; Dall P; Curiel DT
Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
[TBL] [Abstract][Full Text] [Related]
7. Screening of the metastasis-associated genes by gene chip in high metastatic human ovarian cancer cell lines.
Xu S; Mou H; Gu L; Su D; Zhu C; Liu X
J Genet Genomics; 2007 Jul; 34(7):581-90. PubMed ID: 17643943
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for ovarian carcinoma.
Robertson MW; Barnes MN; Rancourt C; Wang M; Grim J; Alvarez RD; Siegal GP; Curiel DT
Semin Oncol; 1998 Jun; 25(3):397-406. PubMed ID: 9633852
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle genes in ovarian cancer: steps toward earlier diagnosis and novel therapies.
D'Andrilli G; Kumar C; Scambia G; Giordano A
Clin Cancer Res; 2004 Dec; 10(24):8132-41. PubMed ID: 15623586
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
[TBL] [Abstract][Full Text] [Related]
13. [Biologic therapy and epithelial ovarian cancer].
Porpiglia M; Vicelli R; Durando A; Fracchioli S; Puopolo M; Katsaros D; Bellino R; Benedetto C
Minerva Ginecol; 2004 Feb; 56(1):91-104. PubMed ID: 14973413
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of ovarian tissues for determination of molecular pathways reflective of tumorigenesis.
Mougeot JL; Bahrani-Mostafavi Z; Vachris JC; McKinney KQ; Gurlov S; Zhang J; Naumann RW; Higgins RV; Hall JB
J Mol Biol; 2006 Apr; 358(1):310-29. PubMed ID: 16503337
[TBL] [Abstract][Full Text] [Related]
15. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
16. Current strategies in cancer gene therapy.
El-Aneed A
Eur J Pharmacol; 2004 Sep; 498(1-3):1-8. PubMed ID: 15363969
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in ovarian carcinomas.
Dahiya N; Morin PJ
Endocr Relat Cancer; 2010 Mar; 17(1):F77-89. PubMed ID: 19903743
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.
Berry NB; Cho YM; Harrington MA; Williams SD; Foley J; Nephew KP
Gynecol Oncol; 2004 Mar; 92(3):896-904. PubMed ID: 14984958
[TBL] [Abstract][Full Text] [Related]
19. Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profiles.
De Smet F; Pochet NL; De Moor BL; Van Gorp T; Timmerman D; Vergote IB; Hartmann LC; Damokosh AI; Hoersch S
Clin Cancer Res; 2005 Nov; 11(21):7958-9; author reply 7959. PubMed ID: 16278422
[No Abstract] [Full Text] [Related]
20. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
